Wealthfront Advisers LLC

SEC CIK: 0001763921
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overview All 13F holders of IBRX Full Q2 2026 holdings

Shares (Q2 2026): 11,528
Value: $100.9K
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of IBRX by Wealthfront Advisers LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	11,528	$100.9K	<0.1%	−4,476−28.0%	Reduced	Holders
Q1 2026	16,004	$122.8K	<0.1%	+16,004	New	Holders
Q4 2025	0	$0	0.0%	−11,249−100.0%	Sold out	Holders
Q3 2025	11,249	$27.7K	<0.1%	+11,249	New	Holders